Literature DB >> 31654330

Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults.

Rika Yoshida1, Takeshi Yoshizako2, Takashi Katsube2, Hajime Kitagaki2.   

Abstract

PURPOSE: This study aimed to characterize the computed tomography (CT) findings of pseudolithiasis and investigate the outcomes and natural history in adult patients receiving CTRX therapy.
METHODS: A total of 17 patients were diagnosed with CTRX-associated biliary pseudolithiasis on CT between April 2013 and March 2017. The medical records, characteristics, complications, treatment options, and outcomes of these patients were examined. Serial CT images and the form, density, and location of pseudolithiasis were reviewed by two radiologists.
RESULTS: Of the 17 patients with CTRX-associated pseudolithiasis, seven were men and ten were women. The median patient age was 78 years (range 31-88 years). The median interval from CTRX administration to the diagnosis of pseudolithiasis was 10 days (range 4-32 days). The CT findings of pseudolithiasis included a sludge pattern (11 patients [64.7%]), stone pattern (two patients [11.8%]), and stone plus sludge pattern (four patients [23.5%]). Seven patients (41.2%) showed gall bladder enlargement along with a common bile duct (CBD) stone. Two patients with CBD stones underwent endoscopic CBD stone removal. The median time to pseudolithiasis resolution after CTRX cessation was 69 days.
CONCLUSION: The high-density sludge pattern is the most common typical CT finding of CTRX-associated pseudolithiasis in adults.

Entities:  

Keywords:  Adult; Biliary pseudolithiasis; CTRX; Ceftriaxone; Computed tomography

Mesh:

Substances:

Year:  2019        PMID: 31654330     DOI: 10.1007/s11604-019-00893-5

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  23 in total

1.  Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.

Authors:  Shinya Murata; Tomoki Aomatsu; Atsushi Yoden; Hiroshi Tamai
Journal:  Pediatr Int       Date:  2015-07-21       Impact factor: 1.524

2.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

3.  Incidence of ceftriaxone-associated gallbladder pseudolithiasis.

Authors:  F Papadopoulou; S Efremidis; S Karyda; M Badouraki; E Karatza; C Panteliadis; K Malaka
Journal:  Acta Paediatr       Date:  1999-12       Impact factor: 2.299

Review 4.  Contemporary review of drug-induced pancreatitis: A different perspective.

Authors:  Whitney Y Hung; Odaliz Abreu Lanfranco
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

5.  Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility.

Authors:  M L Shiffman; F B Keith; E W Moore
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

6.  Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis.

Authors:  D Cohen; G B Appel; B Scully; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

7.  Apparent biliary pseudolithiasis during ceftriaxone therapy.

Authors:  K L Heim-Duthoy; E M Caperton; R Pollock; G R Matzke; D Enthoven; P K Peterson
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Cholelithiasis: evaluation with CT.

Authors:  J A Barakos; P W Ralls; S A Lapin; M B Johnson; D R Radin; P M Colletti; W D Boswell; J M Halls
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

9.  High biliary elimination of ceftriaxone in man.

Authors:  J M Brogard; J F Blickle; F Jehl; J P Arnaud; D Paris-Bockel; H Monteil
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1988-04

10.  A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction.

Authors:  Shuichi Abe
Journal:  IDCases       Date:  2017-06-27
View more
  3 in total

1.  Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.

Authors:  Akane Yamabe; Atsushi Irisawa; Hiroto Wakabayashi; Takuya Tsunoda; Keiichi Tominaga
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

2.  Ceftriaxone-associated Pseudolithiasis in Elderly People: Frequency and Risk Factors.

Authors:  Kiyoshi Hotta; Naohide Hashimura; Masaki Takatsuka; Tomoki Matsuyama; Kouichirou Nakagawa; Tsuneo Yabusako; Shuhei Hosomi; Yasuhiro Fujiwara
Journal:  Intern Med       Date:  2021-12-15       Impact factor: 1.271

3.  Three Dimensional Ultra-short Echo Time MRI Can Depict Cholesterol Components of Gallstones Bright.

Authors:  Mamoru Takahashi; Yasuo Takehara; Kenji Fujisaki; Tomoyuki Okuaki; Yukiko Fukuma; Norihiro Tooyama; Katsutoshi Ichijo; Tomoyasu Amano; Satoshi Goshima; Shinji Naganawa
Journal:  Magn Reson Med Sci       Date:  2020-12-28       Impact factor: 2.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.